-
1
المؤلفون: Francisco Javier Ampudia Blasco, Anders Hasager Boss, Lizheng Shi, Xuejun V. Peng, Robert Lubwama, Julio Rosenstock, Vivian Fonseca
المصدر: Diabetes. 69
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, Internal medicine, Basal insulin, Cohort, Internal Medicine, medicine, Retrospective cohort study, Real world evidence, business, Glucagon-like peptide 1 receptor, Glycemic
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::91886b6dc3a70ae4f62e4ff50a35e551Test
https://doi.org/10.2337/db20-965-pTest -
2
المؤلفون: Vivian Fonseca, Lizheng Shi, Robert Lubwama, Priscilla Hollander, Melvin J. Van Vleet, Eboni G. Price-Haywood, Xuejun V. Peng, Rajeev Ayyagari
المصدر: Diabetes. 68
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, Medical record, Basal insulin, medicine.disease, Glucagon-like peptide-1, Obesity, Internal medicine, Cohort, Internal Medicine, medicine, In patient, business, Dyslipidemia, Glycemic
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::58b9a715c67d144ffe212b59f241d355Test
https://doi.org/10.2337/db19-1116-pTest -
3
المؤلفون: Charlie Cao, John Marcinak, Xuejun V. Peng, Marsha Raanan
المصدر: Diabetes, obesitymetabolism. 19(8)
مصطلحات موضوعية: Male, Endocrinology, Diabetes and Metabolism, Hemoglobins, Abnormal, Drug Resistance, Phases of clinical research, Type 2 diabetes, 030204 cardiovascular system & hematology, Pharmacology, law.invention, Receptors, G-Protein-Coupled, 0302 clinical medicine, Endocrinology, Randomized controlled trial, law, Clinical endpoint, Sulfones, Incidence, Middle Aged, Combined Modality Therapy, Metformin, Sitagliptin, Drug Therapy, Combination, Female, medicine.drug, Agonist, medicine.medical_specialty, medicine.drug_class, 030209 endocrinology & metabolism, Placebo, Incretins, 03 medical and health sciences, Double-Blind Method, Internal medicine, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Benzofurans, Dipeptidyl-Peptidase IV Inhibitors, Dose-Response Relationship, Drug, business.industry, Sitagliptin Phosphate, medicine.disease, Hypoglycemia, United States, Diabetes Mellitus, Type 2, Hyperglycemia, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6cd512aa14a098c505890a087713c53Test
https://pubmed.ncbi.nlm.nih.gov/28239939Test